E-LIB Suche - Ergebnisse für: Krenbek, Dagmar

1

Metabolic tumor volume and sites of organ involvement predi..:

Kifjak, Daria ; Hochmair, Maximilian ; Sobotka, Daniel...
European Journal of Radiology. 170 (2024) - p. 111198 , 2024

Link: https://doi.org/10.1016/..

2

In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulat..:

Dervovic, Dzana ; Malik, Ahmad A. ; Chen, Edward L. Y....
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

3

Neoadjuvant immune-checkpoint inhibitors in lung cancer - a..:

Kifjak, Daria ; Hochmair, Maximilian J. ; Krenbek, Dagmar...
European Journal of Radiology. 161 (2023) - p. 110732 , 2023

Link: https://doi.org/10.1016/..

4

Author Correction: In vivo CRISPR screens reveal Serpinb9 a..:

Dervovic, Dzana ; Malik, Ahmad A. ; Chen, Edward L. Y....
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

5

Multimodal Treatment of Malignant Pleural Mesothelioma: Rea..:

Holzknecht, Arnulf ; Illini, Oliver ; Hochmair, Maximilian J....
Cancers. 14 (2022) 9 - p. 2245 , 2022

Link: https://doi.org/10.3390/..

6

Complete Remission to Afatinib in a Patient Harboring a Nov..:

Hochmair, Maximilian Johannes ; Illini, Oliver ; Prosch, Helmut..
Clinical Lung Cancer. 23 (2022) 4 - p. e289-e292 , 2022

Link: https://doi.org/10.1016/..

7

Real-world experience with capmatinib in MET exon 14-mutate..:

Illini, Oliver ; Fabikan, Hannah ; Swalduz, Aurélie...
Therapeutic Advances in Medical Oncology. 14 (2022) - p. 175883592211032 , 2022

Link: https://doi.org/10.1177/..

8

Characteristics and Treatment Outcomes in Advanced-Stage No..:

Illini, Oliver ; Fabikan, Hannah ; Hochmair, Maximilian Johannes...
Journal of Clinical Medicine. 11 (2022) 14 - p. 4098 , 2022

Link: https://doi.org/10.3390/..

9

Rapid Clinical and Radiologic Responses With Larotrectinib ..:

Hochmair, Maximilian Johannes ; Setinek, Ulrike ; Krenbek, Dagmar...
Clinical Lung Cancer. 21 (2020) 2 - p. e49-e53 , 2020

Link: https://doi.org/10.1016/..

10

The 2020 update of the recommendations of the Austrian work..:

Popper, Helmut H. ; Gruber-Mösenbacher, Ulrike ; Pall, Georg...
memo - Magazine of European Medical Oncology. 13 (2020) 1 - p. 11-26 , 2020

Link: https://doi.org/10.1007/..

11

Later-Line Treatment with Lorlatinib in ALK- and ROS1-Rearr..:

Hochmair, Maximilian J. ; Fabikan, Hannah ; Illini, Oliver...
Pharmaceuticals. 13 (2020) 11 - p. 371 , 2020

Link: https://doi.org/10.3390/..

12

Immune cell landscape in therapy-naïve squamous cell and ad..:

Brcic, Luka ; Stanzer, Stefanie ; Krenbek, Dagmar...
Virchows Archiv. 472 (2018) 4 - p. 589-598 , 2018

Link: https://doi.org/10.1007/..

13

Symptomatic pseudo-progression followed by significant trea..:

Hochmair, Maximilian J. ; Schwab, Sophia ; Burghuber, Otto C...
Lung Cancer. 113 (2017) - p. 4-6 , 2017

Link: https://doi.org/10.1016/..

14

P1.04-001 EGFR, EML4-ALK, ROS 1 and BRAF Testing in Austria..:

Holzer, Sophia ; Hochmair, Maximilian ; Setinek, Ulrike...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S596 , 2017

Link: https://doi.org/10.1016/..

15

MA15.05 PD-L1 Immunohistochemistry as Biomarker in Non-Smal..:

Krenbek, Dagmar ; Weidinger, Barbara ; Jarius, Christa...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S430 , 2017

Link: https://doi.org/10.1016/..